Company: SYRA
Filing Date: 2025-09-19
Form Type: DEF 14A
Source: 0001493152-25-014246
Chunk: 11

Company: Syra Health Corp
Filing Date: 2025-09-19
Form: DEF 14A
Chunk 11
---
</div>

We are committed to good corporate governance practices. These practices provide an important framework within which our Board of Directors and management pursue our strategic objectives for the benefit of our stockholders.

Code of Business Conduct and Ethics

We have adopted a written Code of Business Conduct and Ethics that is applicable to our directors, officers and employees and is designed to deter wrongdoing and to promote:

| ● | honest and ethical conduct;                                                                                                       |
| ● | full, fair, accurate, timely                                                                                                      
 and understandable disclosure in reports and documents that we file with the SEC and in other public communications;              |
| ● | compliance with applicable                                                                                                        
 laws, rules and regulations, including insider trading compliance; and                                                            |
| ● | accountability for adherence                                                                                                      
 to the code and prompt internal reporting of violations of the code, including illegal or unethical behavior regarding accounting 
 or auditing practices.                                                                                                            |

You may obtain a copy of our Code of Business Conduct and Ethics on our website at https://ir.syrahealth.com/governanceunder Investor Relations – Governance. A copy of our Code of Business Conduct and Ethics may also be obtained without charge upon written request to Secretary, Syra Health Corp., 1119 Keystone Way N. #201, Carmel, IN 46032. The Board of Directors has designated the Audit Committee to be responsible for reviewing the Code of Business Conduct and Ethics and making any appropriate updates or amendments. We intend to disclose any changes in this code or waivers from this code that apply to our principal executive officer, principal financial officer, or principal accounting officer by posting such information to our website or by filing with the SEC a Current Report on Form 8-K, in each case if such disclosure is required by SEC rules.

Board Composition and Leadership Structure

We do not have a Chairman of the Board of Directors at this time.

Board’s Role in Risk Oversight

Our Board of Directors believes that open communication between management and the Board of Directors is essential for effective risk management and oversight. Our Board of Directors meets with our Chief Executive Officer and other members of the senior management team at quarterly Board of Director meetings, where, among other topics, they discuss strategy and risks in the context of reports from the management team and evaluate the risks inherent in significant transactions. While our Board of Directors is ultimately responsible for risk oversight, our Board committees assist the Board of Directors in fulfilling its oversight responsibilities in certain areas of risk. The Audit Committee assists our Board of Directors in fulfilling its oversight responsibilities with respect to risk management in the areas of major financial